 If the disease does not respond to treatment by the end of the first cycle with ruxolitinib or dasatinib, you will also receive up to 212 years of chemotherapy treatment. You will receive 8 cycles of intensive chemotherapy, using 2 different chemotherapy schedules. Once you complete intensive chemotherapy, you will receive up to 2 years of maintenance chemotherapy. 